Stock Information
Lineage Cell Therapeutics Inc (LCTX)
Ticker Symbol: LCTX
Exchange: NYSE
Sector: Biotechnology
Market Cap: $438.44 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -0.2782
Revenue (TTM): $0.06 M
Dividend Yield: N/A%
ROE: -130.99%
Latest News
-
Lineage Cell Therapeutics Files Prospectus To Offer Up To $100M In Common Shares, Preferred Shares, Debt, And Warrants
Wed, Mar 11, 2026 9:08 AM
-
Lineage Cell Therapeutics Files $60M ATM Share Offering Prospectus Supplement
Wed, Mar 11, 2026 9:07 AM
Key Financials
Financial data not available
